The Nationals’ decision to shut down starter Stephen Strasburg after his September 7 start last year was controversial, starting a debate that wasn’t even close to settled as the 2013 regular season was under way. The Nationals won the NL East title last season and went into the NLDS against the Cardinals without Strasburg. The Nats were dispatched in five games, leading many to speculate that the organization was being too careful with their 23-year-old phenom, needlessly weakening the team in the franchise’s first playoff appearance since 1981.
This year, the Mets and Marlins took similar precautions with their young aces. The Mets vowed to shut down Matt Harvey early before he ended up suffering an injury, and Jose Fernandez recently made his final start of the year for the Marlins with a few weeks to spare.
As MLB.com’s Anthony Castrovince points out, pitchers are still getting injured quite often despite these preventative measures. Castrovince spoke to a number of people about the issue of pitcher health, including Dr. Marcus Elliott, a physician who trained at Harvard. Elliott said, “I’m certain we’re going to look back on what we did here in 2012, 2013 and not too far into the future and think that it was really primitive.”
Elliott continued, saying, “There are reasons guys end up tearing their ulnar collateral ligament or end up with repetitive trauma to a rotator cuff. There are mechanical explanations for all these things. And we haven’t spent a whole lot of time trying to understand what those reasons are.”
Castrovince also highlighted Arizona State University associate head coach and recruiting coordinator Ken Knutson, citing Knutson’s rather impressive track record of producing pitchers who don’t get injured. According to Knutson, he hadn’t had a pitcher need Tommy John surgery since the beginning of the millennium, and only because the pitcher didn’t follow Knutson’s warmup program. Knutson described that program as a “dynamic body warmup”. “Movements and runs and agility things. We do a lot with body blades or shoulder tubes. We do some strength training with a two-pound medicine ball, then we go through some body movement and throwing heavy balls.”
The entire article is enlightening and worth a dedicated reading. Castrovince raises a very good point, which is that for all of the progress baseball has made over the years in terms of technology and analytics, injury prevention — specifically for pitchers — is an area that has really yet to be broached, let alone conquered.
Pirates pitching coach Ray Searage has become the king of the reclamation project. And it sounds like he’s about to take on another big one …
Travis Sawchik of the Pittsburgh Tribune-Review reports that the Pirates have expressed interest in free agent Justin Masterson. The expectation is that it will be a one-year deal with the goal of rebuilding the right-hander’s value in an environment where many other struggling veteran pitchers have executed significant career turnarounds.
Masterson earned his first (and only) All-Star nod in 2013 when he registered a 3.45 ERA, 195 strikeouts, and three shutouts in 32 appearances with the Indians. But he had a 5.88 ERA in 128 2/3 innings between Cleveland and St. Louis in 2014 and he continued struggling to the tune of a 5.61 ERA with the Red Sox in 2015.
It’s not clear whether the Bucs would try him as a starter or reliever.
Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Tuesday for seven years, $217 million.
Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …
FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.
ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.
Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.
Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.
This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.
Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.
The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.
MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.
The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:
- Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
- 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
- The previous year there were 7,929 total tests with 12 which resulted in discipline;
- There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.
A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.
As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.